Ebola

Featured Article

New Ebola Vaccine Highly Effective in Preventing Spread of Disease

New Ebola Vaccine Highly Effective in Preventing Spread of Disease

A new vaccine for Ebola showed high efficacy in preventing the development of Ebola in clusters of people exposed to the virus, and protection was also conferred to those who were not vaccinated.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News

Blood Test May Determine Chance of Surviving Ebola Infection

Blood Test May Determine Chance of Surviving Ebola Infection

Changes in messenger RNA abundance proved to be a reliable means of predicting patient's chances of surviving Ebola virus disease.

Despite Challenges, Liberia's Semen Screening Program for Ebola Successful

Despite Challenges, Liberia's Semen Screening Program for Ebola Successful

Liberia's Men's Health Screening Program for Ebola survivors successful in spite of complex challenges.

CDC Official Emphasizes Prevention as Data Show Ebola Virus Lingers in Semen

CDC Official Emphasizes Prevention as Data Show Ebola Virus Lingers in Semen

Virus is more likely to be found in male survivors older than 40, researchers report.

Investigational Ebola Vaccine Gets 'Breakthrough Therapy' Designation by FDA

Investigational Ebola Vaccine Gets 'Breakthrough Therapy' Designation by FDA

The FDA's Breakthrough Therapy Designation is intended to expedite the development and review of a candidate vaccine that is planned for use, alone or in combination, to treat a serious or life-threatening disease or condition.

Ebola Virus Infection Control Measures Developed for Hospitals

Ebola Virus Infection Control Measures Developed for Hospitals

The CDC releases infection control measures implemented at a Texas hospital.

Some Ebola Survivors May Develop Visual Impairment

Some Ebola Survivors May Develop Visual Impairment

Approximately one-fifth developed severe or total vision loss within weeks of recovery.

Polyclonal Antibody-Based Product Protected Lab Animals Against Ebola

Polyclonal Antibody-Based Product Protected Lab Animals Against Ebola

Antibody is cost-effective, reducing economic burden that may result from this dangerous virus.

Early Clinical Trials Offer Promising Results for Ebola Vaccine

Early Clinical Trials Offer Promising Results for Ebola Vaccine

One vaccine provided first as a primer, and the second given as a booster.

American Academy of Neurology Officials Say Ebola May Leave Lasting Symptoms

American Academy of Neurology Officials Say Ebola May Leave Lasting Symptoms

Six months after active illness, headaches, memory loss, depression were still being reported.

Mortality 18.5% for Patients Who Received Ebola Care

Mortality 18.5% for Patients Who Received Ebola Care

Most patients received IV fluids and electrolyte supplementation, antibiotics, investigational treatment.

Sign Up for Free e-newsletters